NEW YORK (GenomeWeb News) – Shares of Cepheid fell as low as $14.67 in Wednesday trade on the Nasdaq, nearing a 52-week low of $14.27.
The stock fell following a downgrade from investment bank Piper Jaffray from “Buy” to “Neutral.”
Cepheid’s shares were down 2.5 percent at $15.45 in early afternoon trade. The firm’s stock is down 41 percent since the beginning of the year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.